Pages

▼
Wednesday, July 15, 2009

News from Bayhill on their BHT-3021 Treatment

›
Bayhill is in the middle of a phase-I clinical trial of BHT-3021 which is designed to train the body's immune system not to attack itsel...
Thursday, June 25, 2009

LCT To Start Phase-I Human Trial in New Zealand

›
LCT has (finally) gotten government approval to start a phase-I human trial of their DiabeCell product. This is an encapsulated pig pancrea...
Tuesday, June 23, 2009

Update on Andromedia's DiaPep227: Money to Market

›
You might have seen this recently headline from Reuters: Andromeda says Teva to market diabetes treatment This headline is quite misleadi...
Saturday, June 20, 2009

News from MacroGenics on Teplizumab

›
Two pieces of news from MacroGenics: First, their phase-II human trial of teplizumab (called PROTEGE ) is fully enrolled. Second, they are s...
3 comments:
Friday, May 29, 2009

Exsulin: New Phase-I Research Almost Ready to Start (for Non-Honeymoon Type-1 Diabetes)

›
The Exsulin company is hoping to start Phase-I human trials in June 2009 (so right soon now). They are testing a new formulation of INGAP ...
7 comments:
Wednesday, May 27, 2009

DiaKine starts Phase-I clinical trials on Lisofylline (LSF)

›
DiaKine is about to start it's first clinical trial in a research program aimed at curing type-1 diabetes. Their treatment is Lisofylli...
Monday, May 25, 2009

NovImmune to enter Phase-II with NI-0401 (Another CD3 targeted drug)

›
It looks like NovImmune (a Swiss company) will start phase-II trials of NI-0401, a CD3 targeted drug "this quarter" and hope to ha...